Zhou Z - Search Results

1

Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.

Yang Y, Zhou Z, He S, Fan T, Jin Y, Zhu X, Chen C, Zhang ZR, Huang Y. Yang Y, et al. Among authors: zhou z. Biomaterials. 2012 Mar;33(7):2260-71. doi: 10.1016/j.biomaterials.2011.12.007. Epub 2011 Dec 19. Biomaterials. 2012. PMID: 22189143

2

Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.

Xiang Q, Yang Y, Zhou Z, Zhou D, Jin Y, Zhang Z, Huang Y. Xiang Q, et al. Among authors: zhou z, zhou d. Eur J Pharm Biopharm. 2012 Feb;80(2):379-86. doi: 10.1016/j.ejpb.2011.10.020. Epub 2011 Nov 12. Eur J Pharm Biopharm. 2012. PMID: 22101181

3

Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, Zhang ZR, Zhang Q, Huang Y. Chen C, et al. Among authors: zhou z. Nanomedicine (Lond). 2013 Jul;8(7):1085-100. doi: 10.2217/nnm.12.141. Epub 2012 Oct 17. Nanomedicine (Lond). 2013. PMID: 23075315

4

Combination of mitochondria targeting doxorubicin with Bcl-2 function-converting peptide NuBCP-9 for synergistic breast cancer metastasis inhibition.

Yang J, Li Q, Zhou R, Zhou M, Lin X, Xiang Y, Xie D, Huang Y, Zhou Z. Yang J, et al. Among authors: zhou z, zhou r, zhou m. J Mater Chem B. 2021 Feb 7;9(5):1336-1350. doi: 10.1039/d0tb02564j. Epub 2021 Jan 14. J Mater Chem B. 2021. PMID: 33443508

5

A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages.

Luo C, Zhou M, Chen C, Li S, Li Q, Huang Y, Zhou Z. Luo C, et al. Among authors: zhou z, zhou m. Nanoscale. 2022 Mar 24;14(12):4573-4587. doi: 10.1039/d1nr08215a. Nanoscale. 2022. PMID: 35253829

6

Peritumoral scaffold neutralizes tumor pH for chemotherapy sensitization and metastasis inhibition.

Yan Y, Li J, Yi X, Liu C, Zhou Z, Huang Y, Li L. Yan Y, et al. Among authors: zhou z. J Control Release. 2022 Dec;352:747-758. doi: 10.1016/j.jconrel.2022.11.006. Epub 2022 Nov 10. J Control Release. 2022. PMID: 36356942

7

Mimicking natural cholesterol assimilation to elevate the oral delivery of liraglutide for type II diabetes therapy.

Wu R, Wu Z, Xing L, Liu X, Wu L, Zhou Z, Li L, Huang Y. Wu R, et al. Among authors: zhou z. Asian J Pharm Sci. 2022 Aug;17(5):653-665. doi: 10.1016/j.ajps.2022.08.002. Epub 2022 Sep 24. Asian J Pharm Sci. 2022. PMID: 36382301 Free PMC article.

8

Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs.

Li Y, Xing L, Wang L, Liu X, Wu L, Ni M, Zhou Z, Li L, Liu X, Huang Y. Li Y, et al. Among authors: zhou z. Asian J Pharm Sci. 2023 Mar;18(2):100797. doi: 10.1016/j.ajps.2023.100797. Epub 2023 Mar 1. Asian J Pharm Sci. 2023. PMID: 37035132 Free PMC article.

9

In situ hydrogel enhances non-efferocytic phagocytosis for post-surgical tumor treatment.

Lyu J, Liu H, Chen L, Liu C, Tao J, Yao Y, Li L, Huang Y, Zhou Z. Lyu J, et al. Among authors: zhou z. J Control Release. 2023 Nov;363:402-414. doi: 10.1016/j.jconrel.2023.09.041. Epub 2023 Sep 30. J Control Release. 2023. PMID: 37751825

10

A Less-is-More Strategy for Mitochondria-Targeted Photodynamic Therapy of Rheumatoid Arthritis.

Zuo Q, Lyu J, Shen X, Wang F, Xing L, Zhou M, Zhou Z, Li L, Huang Y. Zuo Q, et al. Among authors: zhou z, zhou m. Small. 2024 Jun;20(25):e2307261. doi: 10.1002/smll.202307261. Epub 2024 Jan 15. Small. 2024. PMID: 38225702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,876 results

Search Page

Filters